Starling Oncology (STLNW) Free Cash Flow (QoQ) (2020 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Free Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Davita | 11.89 Bn | 11.20 Bn | 1.16 Bn |
| 2 | RadNet | 5.51 Bn | 4.78 Bn | 88.08 Mn |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - |
| 6 | Pediatrix Medical | 2.14 Bn | 1.74 Bn | - |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 438.72% |
| Mar 31, 2026 | -249.88% |
| Dec 31, 2025 | 116.42% |
| Sep 30, 2025 | -15.99% |
| Jun 30, 2025 | -114.64% |
| Mar 31, 2025 | -336.79% |
| Dec 31, 2024 | 83.87% |
| Sep 30, 2024 | 106.98% |
| Jun 30, 2024 | -6.02% |
| Mar 31, 2024 | -246.93% |
| Dec 31, 2023 | 48.55% |
| Sep 30, 2023 | 3.72% |
| Jun 30, 2023 | 44.50% |
| Mar 31, 2023 | -8.12% |
| Dec 31, 2022 | 25.93% |
| Sep 30, 2022 | -84.19% |
| Jun 30, 2022 | 34.82% |
| Mar 31, 2022 | 25.71% |
| Dec 31, 2021 | -567.02% |
| Sep 30, 2021 | 51.85% |